Co-Authors
This is a "connection" page, showing publications co-authored by Jaejin An and Kristi Reynolds.
Connection Strength
13.886
-
Cost-effectiveness of implementing a home blood pressure telemonitoring program. Am J Manag Care. 2026 Mar; 32(3):146-152.
Score: 0.966
-
Factors Associated with Treatment Intensification for Uncontrolled Hypertension in a US Health System. J Gen Intern Med. 2026 05; 41(7):1881-1891.
Score: 0.951
-
Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium-Glucose Cotransporter-2 Inhibitors. J Clin Hypertens (Greenwich). 2024 Nov; 26(11):1318-1321.
Score: 0.877
-
Effectiveness and safety of Dabigatran 110 mg versus 150 mg for Stroke Prevention in Patients with Atrial Fibrillation at High Bleeding Risk. Clin Ther. 2023 07; 45(7):e151-e158.
Score: 0.803
-
Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term?Risk. J Am Coll Cardiol. 2023 Feb 21; 81(7):623-632.
Score: 0.784
-
Risk of hospitalization and mortality associated with uncontrolled blood pressure in patients with hypertension and COVID-19. Int J Cardiol Cardiovasc Risk Prev. 2021 Dec; 11:200117.
Score: 0.717
-
Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation. J Am Heart Assoc. 2021 11 02; 10(21):e021601.
Score: 0.716
-
COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system. Int J Cardiol Hypertens. 2021 Jun; 9:100088.
Score: 0.697
-
Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021 01; 9(1).
Score: 0.676
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.673
-
Recurrent Atherosclerotic Cardiovascular Event Rates Differ Among Patients Meeting the Very High Risk Definition According to Age, Sex, Race/Ethnicity, and Socioeconomic Status. J Am Heart Assoc. 2020 12; 9(23):e017310.
Score: 0.671
-
Treatment Patterns and Blood Pressure Control With Initiation of Combination Versus Monotherapy Antihypertensive Regimens. Hypertension. 2021 01; 77(1):103-113.
Score: 0.670
-
Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system. J Hypertens. 2020 08; 38(8):1603-1611.
Score: 0.656
-
Time in suboptimal glycemic control over 10?years for patients newly diagnosed with type 2 diabetes. J Diabetes Complications. 2020 08; 34(8):107607.
Score: 0.645
-
Cardiovascular and Kidney Events Associated with Visit-to-Visit Blood Pressure Variability among Young Adults with Hypertension. Am J Hypertens. 2026 Aug 01; 39(8):988-996.
Score: 0.249
-
Sex Differences in Hypertension Diagnosis Among Young Adults in a US Integrated Health Care System. J Am Heart Assoc. 2026 08 04; 15(15):e042879.
Score: 0.249
-
Trends in Initial Combination Antihypertensive Therapy in a US Health System. Am J Hypertens. 2026 Jun 01; 39(6):787-796.
Score: 0.246
-
PREVENT Equation Performance in Asian and Native Hawaiian and Other Pacific Islander Groups. JAMA Netw Open. 2026 02 02; 9(2):e2556915.
Score: 0.240
-
Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System. J Am Coll Cardiol. 2026 Mar 24; 87(11):1327-1339.
Score: 0.237
-
Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults. J Am Heart Assoc. 2025 Jul 15; 14(14):e040769.
Score: 0.231
-
Lipid-lowering Therapy Utilization, Adherence, and Outcomes Among Adults With and at-Risk for Atherosclerotic Cardiovascular Disease in an Integrated Healthcare Delivery System in Southern California. Am J Cardiol. 2025 Jul 13; 255:55-63.
Score: 0.231
-
Blood Pressure Outcomes Following a Home Blood Pressure Monitoring Program in a Large Integrated US Health System. Am J Hypertens. 2025 May 14.
Score: 0.229
-
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction. J Am Heart Assoc. 2025 Feb 18; 14(4):e039454.
Score: 0.225
-
Association Between Young Adult Characteristics and Blood Pressure Trajectories. J Am Heart Assoc. 2024 Apr 02; e033053.
Score: 0.212
-
Validation of ICD-10 hospital discharge diagnosis codes to identify incident and recurrent ischemic stroke from a US integrated healthcare system. Pharmacoepidemiol Drug Saf. 2023 Aug 01.
Score: 0.202
-
Blood Pressure Control Among Black and White Adults Following a Quality Improvement Program in a Large Integrated Health System. JAMA Netw Open. 2023 01 03; 6(1):e2249930.
Score: 0.194
-
Rates of Acute Myocardial Infarction During the COVID-19 Pandemic. Perm J. 2021 12 13; 25.
Score: 0.180
-
Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis. J Rheumatol. 2016 11; 43(11):1989-1996.
Score: 0.125
-
Treatment discontinuation of oral hypoglycemic agents and healthcare utilization among patients with diabetes. J Diabetes Complications. 2016 Nov - Dec; 30(8):1443-1451.
Score: 0.124
-
Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
Score: 0.122
-
Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1630-1634.
Score: 0.044
-
Association Between Ambulatory Blood Pressure and Coronary Artery Calcification: The JHS. Hypertension. 2021 Jun; 77(6):1886-1894.
Score: 0.043